Page last updated: 2024-10-19

thioctic acid and Dysmenorrhea

thioctic acid has been researched along with Dysmenorrhea in 1 studies

Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.

Dysmenorrhea: Painful menstruation.

Research Excerpts

ExcerptRelevanceReference
"Primary dysmenorrhea is a common gynecologic disorder and is one of the main causes for referral to the gynecology clinic."6.90Effect of alpha-lipoic acid at the combination with mefenamic acid in girls with primary dysmenorrhea: randomized, double-blind, placebo-controlled clinical trial. ( Hesami, S; Kavianpour, M; Khadem Haghighian, H; Rashidi Nooshabadi, M; Yousefi, M, 2019)
"Primary dysmenorrhea is a common gynecologic disorder and is one of the main causes for referral to the gynecology clinic."2.90Effect of alpha-lipoic acid at the combination with mefenamic acid in girls with primary dysmenorrhea: randomized, double-blind, placebo-controlled clinical trial. ( Hesami, S; Kavianpour, M; Khadem Haghighian, H; Rashidi Nooshabadi, M; Yousefi, M, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yousefi, M1
Kavianpour, M1
Hesami, S1
Rashidi Nooshabadi, M1
Khadem Haghighian, H1

Trials

1 trial available for thioctic acid and Dysmenorrhea

ArticleYear
Effect of alpha-lipoic acid at the combination with mefenamic acid in girls with primary dysmenorrhea: randomized, double-blind, placebo-controlled clinical trial.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2019, Volume: 35, Issue:9

    Topics: Adult; Double-Blind Method; Drug Therapy, Combination; Dysmenorrhea; Female; Humans; Iran; Mefenamic

2019